On days 13–16 post tumor injection, SOCS3−/− mice display decreased tumor volume, although not statistically significant, when compared to SOCS3fl/fl tumor volume (Supplementary Figure 3C and 3D). This evidence concerns the gene SOCS3 and neoplasm.